FI4136091T3 - Plasman kallikreiinin estäjien muotoja ja koostumuksia - Google Patents

Plasman kallikreiinin estäjien muotoja ja koostumuksia

Info

Publication number
FI4136091T3
FI4136091T3 FIEP21724430.0T FI21724430T FI4136091T3 FI 4136091 T3 FI4136091 T3 FI 4136091T3 FI 21724430 T FI21724430 T FI 21724430T FI 4136091 T3 FI4136091 T3 FI 4136091T3
Authority
FI
Finland
Prior art keywords
solid form
compound
diffractions
xrpd
theta
Prior art date
Application number
FIEP21724430.0T
Other languages
English (en)
Finnish (fi)
Inventor
Suresh Kumar Tipparaju
Jeffrey Scott Depue
Helge Alfred Reisch
Samuel Alexander Stratford
Joseph Stephen Harris
Sarah Jocelyn Fink
Nikolaos Papaioannou
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Application granted granted Critical
Publication of FI4136091T3 publication Critical patent/FI4136091T3/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/06—Oxalic acid
    • C07C55/07—Salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/10—Succinic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/15—Fumaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FIEP21724430.0T 2020-04-17 2021-04-16 Plasman kallikreiinin estäjien muotoja ja koostumuksia FI4136091T3 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063011776P 2020-04-17 2020-04-17
PCT/US2021/027620 WO2021211930A1 (en) 2020-04-17 2021-04-16 Forms and compositions of inhibitors of plasma kallikrein

Publications (1)

Publication Number Publication Date
FI4136091T3 true FI4136091T3 (fi) 2025-07-25

Family

ID=75870731

Family Applications (1)

Application Number Title Priority Date Filing Date
FIEP21724430.0T FI4136091T3 (fi) 2020-04-17 2021-04-16 Plasman kallikreiinin estäjien muotoja ja koostumuksia

Country Status (9)

Country Link
US (1) US20230167132A1 (enExample)
EP (2) EP4136091B1 (enExample)
JP (2) JP2023522331A (enExample)
DK (1) DK4136091T3 (enExample)
ES (1) ES3035604T3 (enExample)
FI (1) FI4136091T3 (enExample)
PL (1) PL4136091T3 (enExample)
PT (1) PT4136091T (enExample)
WO (1) WO2021211930A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4494698A3 (en) * 2017-08-04 2025-04-23 Takeda Pharmaceutical Company Limited Inhibitors of plasma kallikrein and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
JP5069905B2 (ja) * 2003-01-21 2012-11-07 アプテュイト （ウエスト ラファイエット）、エルエルシー 新規な共結晶化
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
PT3650439T (pt) * 2010-07-23 2021-03-03 Gruenenthal Gmbh Sais ou cocristais de 3-(3-dimetilamino-1-etil-2-metilpropil)fenol
EP2663647A4 (en) * 2011-01-14 2015-08-19 Redwood Bioscience Inc POLYPEPTIDE IMMUNOGLOBULINS WITH ALDEHYDIC MARKING AND THEIR USE METHOD
CN112135825A (zh) * 2018-03-13 2020-12-25 夏尔人类遗传性治疗公司 血浆激肽释放酶抑制剂及其用途

Also Published As

Publication number Publication date
JP2025142238A (ja) 2025-09-30
DK4136091T3 (da) 2025-08-18
PL4136091T3 (pl) 2025-08-18
US20230167132A1 (en) 2023-06-01
EP4136091B1 (en) 2025-05-28
WO2021211930A1 (en) 2021-10-21
EP4623913A3 (en) 2025-12-24
ES3035604T3 (en) 2025-09-05
JP2023522331A (ja) 2023-05-30
PT4136091T (pt) 2025-08-22
WO2021211930A8 (en) 2021-12-16
EP4623913A2 (en) 2025-10-01
EP4136091A1 (en) 2023-02-22

Similar Documents

Publication Publication Date Title
AU2010330585B2 (en) Glyphosate dimethylamine salt crystal, preparation method and use thereof
US20150141383A1 (en) Darunavir Polymorph and Process for Preparation Thereof
CA3125504A1 (en) Solid forms of treprostinil
KR20180011783A (ko) 삼나트륨 발사르탄:사쿠비트릴의 고체 형태
JP2025169363A (ja) ７ｈ－ベンゾ［７］アヌレン－２－カルボン酸誘導体の結晶形態
JP2022104995A (ja) 結晶
EP3173400A1 (de) Kristalline modifikationen von (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
WO2021243192A1 (en) Solid forms of pralsetinib
AU2015369554A1 (en) Crystal forms of apomorphine and uses thereof
TW202602855A (zh) ４－［３－（環丙基甲氧基）－４－（二氟甲氧基）苯乙基吡啶－２（１ｈ）－酮的固體形式及其製備方法
JP2019529481A5 (enExample)
JP2024508378A (ja) ジフェニルピラジン誘導体の製造プロセス
CN117642403A (zh) 1-(8-溴吡啶并[2,3-e][1,2,4]三唑并[4,3-a]吡嗪-4-基)-N-甲基氮杂环丁烷-3-胺半琥珀酸盐的新晶型
US20250073244A1 (en) Crystalline forms of pentaaza macrocyclic ring complex
JP2025069143A (ja) ｔｅｒｔ－ブチル（Ｓ）－２－（（２Ｓ，３Ｒ）－１－アミノ－３－ヒドロキシ－１－オキソブタン－２－イル）－１－オキソ－２，５－ジアザスピロ［３．４］オクタン－５－カルボキシレートの固体形態およびそれらを調製する方法
AU2009325147A1 (en) 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)] heptacosa-1(25),2(26),3,5,8,10,12(27)j16,21,23-decaene citrate salt
JP2023522331A5 (enExample)
CN121368596A (zh) 抗病毒前药的晶型
WO2018229613A1 (en) Solid forms of acalabrutinib and process for preparation thereof
CN117412968A (zh) 1-(8-溴吡啶并[2,3-e][1,2,4]三唑并[4,3-a]吡嗪-4-基)-N-甲基氮杂环丁烷-3-胺硫酸氢盐一水合物的新晶型
KR102133620B1 (ko) 아르베카신 유도체 및 그의 제조 및 이용
CN111108098A (zh) 一种炔基吡啶类脯氨酰羟化酶抑制剂的晶型及其制备方法
US8389722B2 (en) Adefovir dipivoxil crystalline monohydrate form
JP2024511296A (ja) ４ｈ－ピラン－４オンの構造を有するｃｙｐ１１ａ１阻害薬の固体形態
CN101405271A (zh) 利莫那班一水合物，它的制备方法与含有它的药物组合物